Anacor Reworks Collaboration With GSK For Potential Of Additional LeuRS Antibiotics
Six-year deal signed in 2007 may be extended if GSK decides to option additional leucyl-tRNA synthetase candidates discovered by Anacor.
Six-year deal signed in 2007 may be extended if GSK decides to option additional leucyl-tRNA synthetase candidates discovered by Anacor.